| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |